MHI Receives MSCI’s ESG Rating of “AA” for the First Time JCN Newswire

MHI Receives MSCI’s ESG Rating of “AA” for the First Time

TOKYO, Jul 13, 2022 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Heavy Industries, Ltd. (MHI) has received an ESG Rating of "AA" from MSCI(Note) for the first time. The new 2022 rating represents an upgrade from the Company's previous "A" rating, and it demonstrates the high assessment MSCI accords to MHI's ESG initiatives.MSCI's ESG Ratings are given in seven ranked grades in descending order from AAA to CCC, based on the firm's analysis of a company's initiatives relating to environmental, social and governance issues. MSCI's ESG Ratings serve as a global index for making ESG investments.MHI is currently selected for inclusion in all four of the ESG investment indices used by Japan's Government Pension Investment Fund (GPIF), which is the largest pension fund in the world: FTSE Blossom Japan Sector Relative Index, MSCI Japan ESG Select Leaders Index, MSCI Japan Empowering Women Index (WIN), and S&P/JPX Carbon Efficient Index. The Company is also included in the Asia Pacific Index of the Dow Jones Sustainability Index (DJSI), one of the world's leading ESG stock investment indices.Going forward, MHI will continue to harness the power of technology to develop solutions to the world's social issues, marking growth as a business corporation that contributes to achieving a sustainable society and a secure future for the earth and all who inhabit it.MSCI Inc. is an American financial services provider based in New York and listed on the New York Stock Exchange (NYSE). MSCI provides a variety of tools to support investment decisions by institutional investors around the world, including large public pension funds, asset management companies, hedge funds, etc.For further information: https://www.msci.com/About MHI GroupMitsubishi Heavy Industries (MHI) Group is one of the world's leading industrial groups, spanning energy, smart infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on spectra.mhi.com. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More

EQS-News: CICC Initiates Sirnaomics (2257.HK) at Outperform Rating with Target Price of HKD106.00

EQS-News / 04/07/2022 / 17:56 UTC+8 CICC Initiates Sirnaomics (2257.HK) at Outperform Rating with Target Price of HKD106.00 China International Capital Corporation (CICC) initiates coverage of Sirnaomics at “Outperform” rating, with a target price of HKD106.00. CICC said, Sirnaomics is an RNA therapeutics pioneer in China. RNA therapeutics is a rapidly growing field with potential in various indications. Sirnaomics has disclosed over 15 candidates, including two in the clinical stage. STP705 is a siRNA candidate acting as dual TGF-β1/COX-2 inhibitor for local administration. CICC expect STP705 to be marketed in the US in 2024 and in China in 2025, and generate global risk adjusted peak sales of US$617mn in 2031. STP707 is a siRNA candidate also targeting TGF-β1/COX-2 but with potential for systemic administration. CICC expect STP707 to be marketed in 2026 and we estimate it will generate global risk adjusted sales of US$376mn by 2037. Sirnaomics owns proprietary RNA delivery platforms to solve principal challenges to RNAi therapeutics. Sirnaomics has proprietary polypeptide nanoparticle (PNP) and novel N-acetyl galactosamine (GalNAc) delivery platforms. PNP delivery platform allows delivery of both siRNA and mRNA to target cells via local or intravenous administration in low toxicity. It is easy to manufacture and can reach more additional targeted organs other than the liver. CICC believe PNP could have wider use if STP707 has positive read-out in its proof of concept (PoC) trials. Therefore CICC initiates coverage of Sirnaomics at “Outperform” rating. File: CICC Initiates Sirnaomics (2257.HK) at Outperform Rating with Target Price of HKD106.00 04/07/2022 Dissemination of a Financial Press Release, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com
More